Health Highlights: Dec. 29, 2021
Experts answer your questions about the new COVID pills. New antiviral pills for COVID-19 recently authorized for emergency use in high-risk people by the U.S. Food and Drug Administration should give doctors an easier way of keeping people out of the hospital. Read more
CDC lowers estimate of Omicron's prevalence in United States. The latest agency data pegs the variant's prevalence at 59%, a sharp drop from its estimate last week of 73% of all COVID cases. Read more
Fewer U.S. women are losing hearing as they age. A new study finds a significant decline in hearing loss, especially in females. The reasons for these gender differences aren’t known, but researchers believe they could be due to differences in anatomy, smoking habits and noise exposures. Read more
FDA says rapid at-home tests may work less well with Omicron variant. The agency said that antigen tests “do detect the Omicron variant, but may have reduced sensitivity,” meaning it's possible the tests could miss an infection, particularly in the early stages of the disease. Read more
Related Posts
Little Difference Seen in Weight Changes Before, After COVID-19 Shutdown
THURSDAY, June 16, 2022 (HealthDay News) -- Changes in weight or body mass index...
La FDA advierte que las almohadas para corregir la forma de la cabeza son peligrosas para los bebés
VIERNES, 4 de noviembre de 2022 (HealthDay News) -- Las almohadas para corregir...
Higher Carotid Plaque Burden Seen With Persistent Asthma
WEDNESDAY, Nov. 23, 2022 (HealthDay News) -- Higher carotid plaque burden and...
Postpartum Anxiety: What It Is, Symptoms and Treatments
MONDAY, March 13, 2023 (HealthDay News) -- You may have heard of postpartum...